Does Cardiorespiratory Fitness Affect Lung Cancer Risk Among Male Smokers?
Among former male smokers, higher cardiorespiratory fitness is independently linked to a lower risk for lung cancer incidence.
Lung Cancer
Current Lung Cancer Screening Guidelines Suboptimal in Identifying At-Risk Women
Current US Preventive Services Task Force guidelines are not applicable to most women at risk for lung cancer.
The Effect of Smoking Status and Race on Lung Cancer Screening Uptake
Former smokers may be more likely to complete lung cancer screening.
Central Airway Obstruction in Lung Cancer Associated With Poor Survival
Patients with prevalent central airway obstruction at diagnosis with lung cancer may have higher mortality rates than patients without central airway obstruction.
Smoking Cessation Program in Cancer Setting Associated With High Abstinence Rates
In a prospective cohort of smokers, the availability of comprehensive tobacco treatment in the oncology setting was associated with sustained high abstinence rates among patients with cancer and cancer survivors.
Imaging, Diagnostic Procedure Rates Low After LDCT Screening for Lung Cancer
In a commercially insured population of patients, rates of subsequent testing, including imaging and diagnostic procedures, following lung cancer screening with the use of low-dose computed tomography are low.
Early Palliative Care May Improve Survival in Advanced Lung Cancer
Specialist-delivered palliative care may improve survival outcomes in patients with advanced lung cancer.
BCG Vaccination and Cancer Risk: What’s the Link?
BCG vaccination in childhood was associated with a reduced risk of lung cancer development in American Indian and Alaska Native populations.
Electronic Nose Analysis May Predict Response to Anti-PD-1 Therapy in NSCLC
Initial breath analysis predicted individual treatment response to anti-PD-1 therapy at 3 months.
Antibiotic Use May Affect Lung Cancer Survival When Treated With Pembrolizumab
In patients with naïve advanced NSCLC and high PD-LI expression who are treated with pembrolizumab, the use of IV antibiotics may negatively impact progression free survival and overall survival.
Next post in Lung Cancer
